Terns Pharmaceuticals (TERN) Accounts Payables: 2020-2022

Historic Accounts Payables for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $1.6 million.

  • Terns Pharmaceuticals' Accounts Payables rose 58.79% to $3.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.3 million, marking a year-over-year increase of 58.79%. This contributed to the annual value of $1.6 million for FY2022, which is 22.62% down from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Accounts Payables of $1.6 million as of FY2022, which was down 22.62% from $2.1 million recorded in FY2021.
  • In the past 5 years, Terns Pharmaceuticals' Accounts Payables ranged from a high of $2.1 million in FY2021 and a low of $935,000 during FY2020.
  • Its 3-year average for Accounts Payables is $1.6 million, with a median of $1.6 million in 2022.
  • Per our database at Business Quant, Terns Pharmaceuticals' Accounts Payables soared by 127.38% in 2021 and then fell by 22.62% in 2022.
  • Over the past 3 years, Terns Pharmaceuticals' Accounts Payables (Yearly) stood at $935,000 in 2020, then spiked by 127.38% to $2.1 million in 2021, then declined by 22.62% to $1.6 million in 2022.